Skip to main content
High RiskFDAfda-F-0045-2022UNDECLARED ALLERGEN

Chocolate & the Chip Gluten free sweetie: Cookies: 4 oz / 114 grams per pack. Cookies are packaged in uniform pairs in a food grade cle...

Category
Units Affected
3,000
Recall Date
October 5, 2021
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0045-2022.

Inspection by the California Department of Public Health found undeclared allergens in numerous bakery products.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0045-2022.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Chocolate And The Chip or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0045-2022.

Chocolate and the Chip

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Chocolate And The Chip Recall FAQ

Chocolate And The Chip is the subject of a dairy safety report: Chocolate & the Chip Gluten free sweetie: Cookies: 4 oz / 114 grams per pack. Cookies are packaged in uniform pairs in a food grade cle.... The notice was published on October 5, 2021 by the U.S. Food and Drug Administration (FDA). Approximately 3,000 units are potentially affected.